These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25454487)

  • 1. Myeloid cells in cancer-related inflammation.
    Caronni N; Savino B; Bonecchi R
    Immunobiology; 2015 Feb; 220(2):249-53. PubMed ID: 25454487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid regulatory cells in tumor spreading and metastasis.
    Keskinov AA; Shurin MR
    Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory chemokines and metastasis--tracing the accessory.
    Borsig L; Wolf MJ; Roblek M; Lorentzen A; Heikenwalder M
    Oncogene; 2014 Jun; 33(25):3217-24. PubMed ID: 23851506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?
    Brandau S; Moses K; Lang S
    Semin Cancer Biol; 2013 Jun; 23(3):171-82. PubMed ID: 23459190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
    Atretkhany KN; Drutskaya MS
    Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cell infiltration of tumors: Jekyll or Hyde.
    Talmadge JE; Donkor M; Scholar E
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
    Ye XZ; Yu SC; Bian XW
    J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulation by ER stress and inflammation in the tumor microenvironment.
    Rodvold JJ; Mahadevan NR; Zanetti M
    Cancer Lett; 2016 Sep; 380(1):227-36. PubMed ID: 26525580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into chronic inflammation-induced immunosuppression.
    Kanterman J; Sade-Feldman M; Baniyash M
    Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma-induced immunosuppression and its neutralization.
    Umansky V; Sevko A
    Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.
    Clements DR; Sterea AM; Kim Y; Helson E; Dean CA; Nunokawa A; Coyle KM; Sharif T; Marcato P; Gujar SA; Lee PW
    J Immunol; 2015 May; 194(9):4397-412. PubMed ID: 25825443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle.
    Wattenberg MM; Beatty GL
    Semin Cancer Biol; 2020 Oct; 65():38-50. PubMed ID: 31954172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer.
    Raz Y; Erez N
    Exp Cell Res; 2013 Jul; 319(11):1596-603. PubMed ID: 23567181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.
    Eruslanov E; Daurkin I; Vieweg J; Daaka Y; Kusmartsev S
    Int Immunopharmacol; 2011 Jul; 11(7):848-55. PubMed ID: 21315786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16-associated tumors control myeloid cell homeostasis in lymphoid organs, generating a suppressor environment for T cells.
    Stone SC; Rossetti RA; Bolpetti A; Boccardo E; Souza PS; Lepique AP
    J Leukoc Biol; 2014 Oct; 96(4):619-31. PubMed ID: 24970861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting myeloid cells in the tumor sustaining microenvironment.
    Schupp J; Krebs FK; Zimmer N; Trzeciak E; Schuppan D; Tuettenberg A
    Cell Immunol; 2019 Sep; 343():103713. PubMed ID: 29129292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation fires up cancer metastasis.
    Qian BZ
    Semin Cancer Biol; 2017 Dec; 47():170-176. PubMed ID: 28838845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.